Litcius/Paper detail

Molecular Docking Study on Some Isonicotinoyl Hydrazide Derivatives as Potential Inhibitors of COVID-19

Nasser Mohammed Hosny, Yousery Sherif, P Lee, P Hsueh, M Arba, Arfan, A Nuralifah, W Haerunnisah, L Kadidae, A Radwan, M Khalid, H Amer, M Alotaibi, R Lu, X Zhao, J Li, P Niu, B Yang, H Wu, W Wang, H Song, B Huang, N Zhu, Y Bi, X Ma, F Zhan, L Wang, T Hu, H Zhou, Z Hu, W Zhou, L Zhao, J Chen, Y Meng, J Wang, Y Lin, J Yuan, Z Xie, J Ma, W Liu, D Wang, W Xu, E Holmes, G Gao, G Wu, W Chen, W Shi, W Tan, J Cui, F Li, Z Shi, S John, S Tomar, S Stauffer, A Mesecar, D Rao, K Kaymakolu, S Rollas, Synthesis, E Bavin, D Drain, M Seiler, D Seymour, P Buu-Hoi, D Xuong, H Nam, F Binon, R Royer, M Cocco, C Congiu, V Onnis, M Pusceddo, M Schivo, A De Logu, M Abdel-Rhman, M Hussien, H Mahmoud, N Hosny, N Hosny, H Mahmoud, M Abdelrhman, N Hosny, N Hassan, H Mahmoud, M Abdelrhman, N Hosny, N Hassan, H Mahmoud, M Abdel-Rhman, N Hosny, A Shallaby, N Hosny, Pro

2020Letters in Applied NanoBioScience16 citationsDOIOpen Access PDF

Abstract

Coronavirus (COVID-19) is more than a health disaster;it is the greatest challenge that the world confrontsnowadays. There is a race to slow the spread of this disease. Searching for an antiviral agent to stop COVID-19 is an essential demand since there is no approved drug for COVID-19 till now. Molecular docking is a powerful tool in predicting new drugs. In this study, Favpiravir (Avigan), Hydroxychloroquine, and a series of biologically active compounds derived from iso-nicotinoyl hydrazide have been chosen for molecular docking study. Molecular docking was carried out by theMolegro virtual docker program on proteaseenzyme of COVID-19.The results showed that all the studied molecules are located in the active sites of protease after molecular docking. The tested nicotinoyl hydrazide derivatives showed a higher ranking docking score than Favpiravir (Avigan). According to the docking score ranking rearrangement, Hydroxychloroquine comes the third, and Favpiravir comes the last among the tested compounds. N(2-iso-nicotinoyl hydrazine-carbonthioyl)benzamide(2) and the enol form of (E)-N-(1-phenylethylidene)-nicotinohydrazide(7) have shown the highest docking score (123.23 and -123.12 kcal/mol respectively) among the tested compounds. Ligands (2) and (7) are expected to be potential inhibitors of the main protease enzyme of coronavirus.

Topics & Concepts

Docking (animal)ChemistryStereochemistryHydrazideCoronavirus disease 2019 (COVID-19)Active siteProtein Data Bank (RCSB PDB)HydroxychloroquineCombinatorial chemistryEnzymeBiochemistryOrganic chemistryMedicineInfectious disease (medical specialty)NursingPathologyDiseaseComputational Drug Discovery MethodsSynthesis and biological activityDiverse Scientific Research Studies
Molecular Docking Study on Some Isonicotinoyl Hydrazide Derivatives as Potential Inhibitors of COVID-19 | Litcius